Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2019 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Microsatellite Stable Ovarian Carcinoma"
Page 1
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Gynecol Oncol. 2020 Jan;156(1):194-202. doi: 10.1016/j.ygyno.2019.10.028. Epub 2019 Nov 19.
Gynecol Oncol. 2020.
PMID: 31757464
Free PMC article.
MSIsensor scores were conclusive for 21 samples: 19 were microsatellite stable and 2 MSI-high. After median follow-up of 30 months, 4/23 (17%) developed recurrences: 3 with initial grade 3 stage I and 1 with grade 1 stage III disease. ...CONCLUSIONS: Patients with P …
MSIsensor scores were conclusive for 21 samples: 19 were microsatellite stable and 2 MSI-high. After median follow-up of 30 mo …
Comparison of Mismatch Repair Status Between Primary and Matched Metastatic Sites in Patients With Colorectal Cancer.
He WZ, Hu WM, Wang F, Rong YM, Yang L, Xie QK, Yang YZ, Jiang C, Qiu HJ, Lu JB, Zhang B, Ding PR, Xia XJ, Shao JY, Xia LP.
He WZ, et al.
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1174-1183. doi: 10.6004/jnccn.2019.7308.
J Natl Compr Canc Netw. 2019.
PMID: 31590148
Of the 46 patients with MSI-high primary tumors, 37 (80.4%) also had MSI-high metastatic tumors, whereas 9 (19.6%) had microsatellite stable (MSS) metastatic tumors. ...Rebiopsy to evaluate MSI-high/dMMR status might be needed during the course …
Of the 46 patients with MSI-high primary tumors, 37 (80.4%) also had MSI-high metastatic tumors, whereas 9 (19.6%) had microsatell …
Item in Clipboard
A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer.
Watanabe Y, Koi M, Hemmi H, Hoshai H, Noda K.
Watanabe Y, et al.
Br J Cancer. 2001 Sep 28;85(7):1064-9. doi: 10.1054/bjoc.2001.2037.
Br J Cancer. 2001.
PMID: 11592780
Free PMC article.
To clarify the mechanism of acquired CDDP resistance in ovarian cancer, we compared the microsatellite instability (MSI) by the amplification of 10 microsatellite loci and immunohistochemical detection of hMSH2 and hMLH1 expression between the primary resecte …
To clarify the mechanism of acquired CDDP resistance in ovarian cancer, we compared the microsatellite instability (MSI) by th …
Item in Clipboard
Cite
Cite